Lilly’s Olumiant (baricitinib) and Abbvie’s Rinvoq (upadacitinib) got health insurance benefits starting from May 1 to treat severe atopic dermatitis.Patients who used the two drugs to treat severe atopic dermatitis without health insurance will be able to get insurance benefits as long as they meet
People’s interest in decentralized clinical trials (DCTs) grew due to the Covid-19 pandemic as patients found it difficult to visit clinical trial sites.However, a government report showed that Korea still ranked low in the proportion of DCTs out of all clinical trials.Korea National Enterprise for
Ferring’s Rekovelle (follitropin delta), a treatment to promote egg production in ovaries, became reimbursable when used in combination with human menopausal gonadotropin (hMG) in women receiving in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).Ferring Korea said Rekovelle got
Celltrion Healthcare said that it would expand direct sales, previously limited to only some products, to all products in the European market.The company has sold Remsima (ingredient: infliximab), a biosimilar for treating autoimmune diseases, directly in Europe since 2019. Since then, despite inten
Hanmi Pharmaceutical said that Aptose Biosciences, its American partner, has received orphan drug designation (ODD) for HM43239, an acute myeloid leukemia (AML) treatment, from the U.S. Food and Drug Administration.The company had licensed out the treatment to Aptose in November.Under the deal, Hanm
BMS’ anemia treatment Reblozyl (ingredient: luspatercept) arrived in the Korean market only two and a half years after the company completed drug development in the U.S.The Ministry of Food and Drug Safety authorized Reblozyl to treat adult anemia patients who failed an erythropoiesis-stimulating ag
Although the decline of new Covid-19 cases stagnated over the weekend, quarantine officials predicted on Monday that there would be no sudden increase for the time being."The decline in the Covid-19 prevalence is slowing down," said Son Young-rae, head of the social strategy team in the Central Disa
The government should raise the status of the Korea Disease Control and Prevention Agency (KDCA) to the tentatively titled “Ministry of Health” to integrate the management and operation of the public health system.The Korea Institute of Public Administration, a government-financed research organizat
Korea Atomic Energy Research Institute (KAERI) said that it has exported Germanium-68, a medical radioactive isotope, to Sanders Medical, a U.S. medical device company.According to the state-invested institute, the contract with Sanders Medical marks the first time that Korea has exported a radioact
Coreline Soft said that it would supply AVIEW LCS PLUS, an artificial intelligence-based solution for diagnosing chest diseases, to St. Mary Hospital, in Yilan County, Taiwan.AVIEW LCS PLUS is a device that automatically analyzes and quantifies the image data obtained from a single chest computed to
A research team at CHA University Gangnam Women's Hospital has discovered a biomarker for the risk assessment of recurrent pregnancy loss (RPL) among Korean women.RPL refers to a case when a pregnant woman has two or more consecutive miscarriages before 20 weeks into her pregnancy.Many factors influ
Forxiga (dapagliflozin) and Jardiance (empagliflozin), the two representative SGLT-2 inhibitors, are competing not only in diabetes but cardio and renal diseases.On Thursday, AstraZeneca said Forxiga met the primary endpoint in a large-scale global phase 3 study, DELIVER, reducing the risk of cardio
Shionogi, a Japanese pharmaceutical company, halted its phase 2/3 trial of S-217622, an oral Covid-19 treatment candidate, in the Philippines.According to Philippine Health Research Registry on Monday, Shionogi updated the S-217622 phase 2/3 clinical trial status in the Philippines to “terminated” a
“I wonder if spending much energy to overhaul government organizations for every new administration will be effective. But, on the other hand, if the energy is used to help the current organizations to work properly, the government can provide value-added policy for people.”Kim Gang-lip, Minister of
"We must be wary of unwarrantedly denigrating quarantine results achieved through the participation of the whole nation by enduring pain and discomfort," Prime Minister Kim Boo-kyum said Monday.Kim, the Covid-19 czar of the Moon Jae-in administration, said so while presiding over the last daily quar
HLB said that its U.S. subsidiary Elevar Therapeutics has started marketing Apealea, an ovarian cancer treatment, in Germany after listing the drug on Gelbe Liste, a German drug distribution website.Elevar acquired the global rights for the drug from Vivesto, the original developers, in March 2020.
AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan), the second-generation antibody-drug conjugate (ADC) that showed superiority to Roche’s Kadcyla in HER2-positive breast cancer treatment, received U.S. approval for patients with metastatic HER2-positive breast cancer after one p
Hugel said on Friday that it received a clinical study report (CSR) on the phase 1 trial of HG102, a lidocaine-containing liquid botulinum toxin (BTX), on Wednesday.HG102 is made into liquid from the existing BTX in a freeze-dried powder form. It contains lidocaine hydrogen chloride, a local anesthe
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have elucidated the three-dimensional atomic structure of somatostatin, a hormone-regulating substance that inhibits hormone secretion through its receptor somatostatin receptor 2 complex (SSTR2).Somatostatin is a hormone
Health authorities have started to check for a new nitrosamine impurity in quetiapine medicines.Quetiapine is a treatment for schizophrenia and has a prescription market size of 30 billion won ($23.7 million). The original product is Alvogen Korea’s Seroquel, with 30 pharmaceutical companies selling